A review of the effectiveness of psychological interventions used for anxiety and depression in chronic obstructive pulmonary disease

Sheree M S Smith, Sandra Sonego, Leah Ketcheson, Janet L Larson, Sheree M S Smith, Sandra Sonego, Leah Ketcheson, Janet L Larson

Abstract

Background: Anxiety and depression are recognised co-morbidities associated with COPD and have been related to poor health outcomes. Therapies to relieve anxiety and depression are currently not detailed in clinical guidelines.

Methods: A systematic review of psychological interventions for anxiety and depression in adults with COPD was conducted. Meta-analysis utilising the random effects model was undertaken for 4 studies that employed the same psychological intervention type, Cognitive Behavioural Therapy (CBT).

Results: Seven studies met the inclusion criteria. Four studies used CBT. Included studies utilised psychotherapy, uncertainty management and minimal psychological therapy. 70% of participants were male. Many studies had poor methodological quality. The meta-analysis showed a small decrease in symptoms for both anxiety (SMD -0.49, 95% CI -1.04, 0.06, P=0.08, n=193) and depression (SMD -0.37, 95% CI -0.86, 0.11, P=0.13, n=193). No change occurred when sensitivity analyses were conducted.

Conclusion: Anxiety and depression in COPD patients are known to impact on health outcomes. Effective psychological interventions such as CBT may assist people with COPD in reducing psychological burden. There remains a need for well-designed studies to provide substantive evidence for the use of psychological interventions in this patient population.

Figures

Figure 1
Figure 1
Effects of cognitive behaviour therapy (CBT) interventions on symptoms of anxiety in chronic obstructive pulmonary disease (COPD). Random effects model used. SMD, Standardised Mean Difference.
Figure 2
Figure 2
Effects of cognitive behaviour therapy (CBT) interventions on symptoms of depression in chronic obstructive pulmonary disease (COPD). Random effects model used. SMD, Standardised Mean Difference.

References

    1. World Health Organization. Global burden of disease. Secondary Global burden of disease 01/06/2013 2004.
    1. Marinho P, Castro C, Raposo C et al. . Depressive symptoms, inflammatory markers and body composition in elderly with and without chronic obstructive pulmonary disease (COPD). Arch Gerentol Geriatr 2012;54:453–8.
    1. Kuhl K, Schurmann W, Rief W. Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis 2008;3:727–36.
    1. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165–85.
    1. Global Initiative for Chronic Obstructive Lung Disease. Management and prevention of chronic obstructive pulmonary disease. Secondary management and prevention of chronic obstructive pulmonary disease 2010.
    1. Dahlén I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002;122:1633–7.
    1. Yohannes A, Baldwin R, Connolly M. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerentology 2000;10:193–202.
    1. Burgess A, Kunik M, Stanley M. Chronic obstructive pulmonary disease: assessing and treating psychological issues in patients with COPD. Geriatrics 2005;60:18–21.
    1. Hynninen M, Pallesen S, Nordhus I. Factors affecting health status in COPD patients with co-morbid anxiety or depression. Int J Chron Obstruct Pulmon Dis 2007;2:323–8.
    1. Lamers F, Jonkers CC, Bosma H et al. . Improving quality of life in depressed COPD patients: effectiveness of a minimal psychological intervention. COPD 2010;7:315–22.
    1. Rose C, Wallace L, Dickson R et al. . The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Patient Educ Couns 2002;47:311–18.
    1. Cafarella PA, Effing TW, Usmani ZA et al. . Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology 2012;17:627–38.
    1. Cully J, Graham D, Stanley M et al. . Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006;47:312–19.
    1. Jacobs J, Lisdonk Evd, Smeele I et al. . Management of patients with asthma and COPD: monitoring quality of life and the relationship to subsequent GP interventions. Fam Pract 2001;18:574–80.
    1. Stanley MA, Veazey C, Hopko D et al. . Anxiety and depression in chronic obstructive pulmonary disease: a new intervention and case report. Cogn Behav Pract 2005;12:424–36.
    1. Kim H, Kunik M, Molinari V et al. . Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000;41:465–71.
    1. Laurin C, Moullec G, Bacon S et al. . The impact of psychological distress on exacerbation rates in COPD. Ther Adv Respir Dis 2011;5:3–18.
    1. Lacasse Y, Goldstein R, Lasserson T et al. . Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;18:1–7.
    1. Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Educ Couns 2011;83:29–36.
    1. Norweg A, Whiteson J, Malgady R et al. . The effectiveness of different combinations of pulmonary rehabilitation program components: a randomized controlled trial. Chest 2005;128:663–72.
    1. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 2009;38:34–47.
    1. Liberati A, Altman DG, Tetzlaff J et al. . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
    1. American Psychological Association. Presidential task force on evidence-based practice in psychology 2005 policy statement. Secondary Presidential task force on evidence-based practice in psychology 2005 policy statement 2005.
    1. Pai A, Drotar D, Zebracki K et al. . A meta-analysis of the effects of psychological interventions in pediatric oncology on outcomes of psychological distress and adjustment. J Pediatr Psychol 2006;31:978–88.
    1. Critical Appraisal Skills Programme. Critical Appraisal Skills Programme: Making sense of evidence. Secondary Critical Appraisal Skills Programme: Making sense of evidence 2013.
    1. Scottish Intercollegiate Guidelines Network. Critical appraisal: Notes and checklists. Secondary Critical appraisal: Notes and checklists 2014.
    1. Deeks J, Higgins J, Altman D. Chapter 9: analysing data and undertaking meta-analyses. In: Higgins J, Green S, eds. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons Ltd. 2008:243–93.
    1. Coventry PA, Bower P, Keyworth C et al. . The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS ONE 2013;8:e60532.
    1. Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br J Health Psychol 2008;13:381–400.
    1. Borenstein M, Hedges LV, Higgins JPT. Introduction to meta-analysis. Hoboken, NJ: John Wiley & Sons, 2009.
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edn: Lawrence Erlbaum Associates, 1988.
    1. de Godoy DV, de Godoy RF. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003;84:1154–7.
    1. Hynninen M, Bjerke N, Pallesen S et al. . A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med 2010;104:986–94.
    1. Jiang X, He G. Effects of an uncertainty management intervention on uncertainty, anxiety, depression, and quality of life of chronic obstructive pulmonary disease outpatients. Res Nurs Health 2012;35:409–18.
    1. Kunik ME, Braun U, Stanley MA et al. . One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001;31:717–23.
    1. Kunik ME, Veazey C, Cully JA et al. . COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med 2008;38:385–96.
    1. Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in COPD. Eur Respir J 2010; 35:557–63.
    1. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S467–72.
    1. Spielberger C, Gorsuch R, Lushene R et al. . Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press, 1983.
    1. Smarr KL, Keefer AL. Measures of Depression and Depressive Symptoms Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthrtitis Care and Research (Hoboken) 2011;63(Suppl 11):S454–66.
    1. Beck A, Steer R, Garbin M. Psychometric properties of the Beck Depression Inventory twenty-five years of evaluation. Clin Psychol Rev 1988;8:77–100.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa